GroPep infertility data presented at US meeting

GroPep's program to develop a treatment for infertility reached another milestone with the release of key data at the 25th Anniversary Meeting of the American Society for Reproductive Immunology in the US. The data will be presented by a leading international researcher in infertility.

More than 50% of recurrent miscarriages have no apparent explanation* and the market for a drug to correct this is potentially worth up to US$750 million annually.

Following the success of pre-clinical studies performed at McMaster University in Canada, the GroPep drug is on track to be tested in Phase I trials during 2006.

A leading international infertility researcher, Professor David Clark, will present key pre-clinical data on GroPep's infertility drug, PV903, at the 25th Anniversary Meeting of the American Society for Reproductive Immunology in Providence, Rhode Island, 16-18 June 2005.

Professor Clark's research found that administration of a single dose of the GroPep drug PV903 halved the miscarriage rate in a strain of female mice susceptible to the immune rejection of the foetus (a suspected major cause of recurrent miscarriage in women).

Scientists believe that women who suffer from repeated miscarriage have an immune system that attacks the embryo as "foreign" in the same way it would a virus or bacteria. The GroPep drug contains an active ingredient found in semen (called a "cytokine") that is thought to instruct the mother's immune system to "tolerate" the foetus.

Professor Clark, who was President of the American Society for Reproductive Immunology between 1996 and 1998, said: "This is the first time a cytokine has been shown to positively affect reproductive outcome in an animal model of reproductive failure that shares many pathological features with recurrent miscarriage in humans. Clinical trials in women with a history of recurrent miscarriage are warranted."

He further noted that: "Past advances in endo

Contact: Mr Tony Mitchell
Research Australia

Page: 1 2

Related biology news :

1. GroPep announces US FDA approval of biopharmaceutical that uses its cell culture product
2. GroPep announces Japanese approval of biopharmaceutical that uses its cell culture products
3. Male or female factor infertility -- men suffer just the same
4. Risk-taking in infertility treatment correlates with womens negative moods
5. New research holds promise for protecting cancer patients against infertility
6. Stressed-out African naked mole-rats may provide clues about human infertility
7. Key to male infertility
8. Researchers find gene mutation that causes infertility in male mice
9. Treating male infertility with stem cells
10. Eating ice cream may help women to conceive, but low-fat dairy foods may increase infertility risk
11. World-first stem cell research could aid male infertility

Post Your Comments:

(Date:6/27/2019)... IRVINE, Calif. (PRWEB) , ... June 27, 2019 , ... ... from the Illuminating Energy Society (IES), which honored the designers for creating both engaging ... area of 701B Street , an office tower in San Diego, California earned ...
(Date:6/19/2019)... ... June 19, 2019 , ... Dahryn Trivedi, today released research results ... Sodium, antibiotic which can prove to be beneficial for treating multiple bacterial diseases. , ... amount , Over 68% decrease in weight , Over ...
(Date:6/14/2019)... ... , ... Molecular diagnostics segment is the fastest-growing segment within the global IVD ... segments that are expected to drive the growth are infectious diseases, cancer, and transplant ... Kalorama’s The World Molecular Diagnostics Market, 8th Edition . , The discovery of ...
Breaking Biology News(10 mins):
(Date:6/26/2019)... , ... June 26, 2019 , ... Alice Branton today ... on improving physicochemical properties of Magnesium Gluconate, which can prove to be beneficial for ... alteration of characteristic differentiation peak, change in crystallite size , Over 142% ...
(Date:6/11/2019)... (PRWEB) , ... June 10, 2019 , ... ... of its distribution network with the appointment of Biofeedback Tech Ltd ... monitoring systems are an essential part of many therapeutic treatments and clinical assessment ...
(Date:6/11/2019)... Calif. (PRWEB) , ... June 11, 2019 , ... ... company of Personalized Stem Cells Inc. (PSC) , has announced that their ... Public Health, Food and Drug Branch for manufacturing. This is an important ...
(Date:5/31/2019)... Redwood City, California (PRWEB) , ... ... ... received allowance of our patent applications from the USPTO providing proprietary interest ... SYSTEM AND METHOD FOR SLEEP DISORDER DIAGNOSIS AND TREATMENT… extends Somnology’s IP ...
Breaking Biology Technology:
Cached News: